Skip to content
StakeWorld UK is your ultimate guide to blockchain technolo…

Zimbabwe Turns Down ‘Unbalanced’ US Healthcare Assistance Deal Over Data Apprehensions

Health aid illustration
The proposed American funding would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive biological samples.

This rejection came to light after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

An official spokesman later explained that the United States was seeking health data for scientific study and commercial purposes but was not willing to guarantee the benefits from any future vaccines.

"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for continued talks to find a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Background

This rejection follows a similar situation in Kenya, where a high court halted a related deal with the US following concerns were filed about the safety of citizens' medical information.

Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and responsibility.

Based on statements, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"Put simply, our nation would provide the basic resources for medical research with no certainty that the resulting innovations would be accessible to our population if a new health crisis emerge."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were upending frameworks already established via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage future pandemics.

"This system is intended to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."

The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We encourage ongoing discussions with our American counterparts on how subsequent co-operation might be structured in a manner that honours the sovereignty and interests of both nations."

Medical Community Response

A leading public health body expressed it understood the government's concerns, but suggested that talks should continue considering much of the nation's HIV programmes depended on external financing.

"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.

The halted deal underscores the ongoing debate between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.

SL
About the author

Scott Lewis

Oliver Bennett is a blockchain enthusiast and freelance writer covering crypto innovations and decentralized technologies.

StakeWorld UK

Type to search articles.